Brief: Kane Biotech Announces New Agreement With FreeMind Group
16/07/2019 12:21
July 16 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES NEW AGREEMENT WITH FREEMIND GROUP
* KANE BIOTECH INC - AGREEMENT WITH FREEMIND GROUP WILL
SUPPORT
STRATEGY OF SECURING NON-DILUTIVE FUNDING FROM A VARIETY OF
SOURCES
* KANE BIOTECH INC - NON-DILUTIVE FUNDING WILL FURTHER
PROGRESS
WITH RESEARCH AND DEVELOPMENT IN ANIMAL AND HUMAN HEALTH SECTORS
Source text for Eikon: ID:nGNX4V04GX
Further company coverage: KNE.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update